JMS Co

JMS Co Intangible Assets

The Intangible Assets of JMS Co (7702.T) as of Nov 3, 2026 is 647.00 M JPY. In the previous year, Intangible Assets was 680.00 M JPY — a change of -4.85% (lower).

Intangible Assets

647.00 MJPY

YoY

-4.85%

Last updated:

Intangible Assets of JMS Co is 2025 647.00 M JPY. Intangible Assets of JMS Co was 2024 680.00 M JPY. It decreases by -4.85% lower compared to the previous year.

The JMS Co Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2018
438.00 M JPY
Jan 1, 2019
503.00 M JPY
Jan 1, 2020
538.00 M JPY
Jan 1, 2021
692.00 M JPY
Jan 1, 2022
901.00 M JPY
Jan 1, 2023
728.00 M JPY
Jan 1, 2024
680.00 M JPY
Jan 1, 2025
647.00 M JPY
The JMS Co Intangible Assets history
YEARIntangible AssetsYoY
647.00 MJPY-4.85%
680.00 MJPY-6.59%
728.00 MJPY-19.20%
901.00 MJPY+30.20%
692.00 MJPY+28.62%
538.00 MJPY+6.96%
503.00 MJPY+14.84%
438.00 MJPY-2.23%
448.00 MJPY-11.81%
508.00 MJPY-18.98%
627.00 MJPY-14.11%
730.00 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JMS Co Stock analysis

What does JMS Co do? JMS Co., Ltd. generates revenue through the manufacture, sale, export, and import of medical devices and pharmaceuticals across its five geographical segments: Japan, Singapore, China, Philippines, and Germany. The company offers a range of products including infusion and nutrition products, dialysis products, surgery products, blood and cell products, and other related items. Key products such as infusion & transfusion sets, syringe pumps, surgical gowns, dialysis kits, peritoneal dialysate, microcatheters, and blood bags are sold to healthcare providers and institutions within these regions. The firm also provides maintenance services and other related services as part of its product portfolio. The company's primary customers are healthcare providers and institutions in Japan, Singapore, China, Philippines, and Germany, where it operates through its five geographical segments. These customers purchase medical equipment and drugs, including specific items like infusion & transfusion sets, dialysis kits, and surgical gowns. The firm's product lines are tailored to meet the needs of hospitals, clinics, and other medical facilities across its operational regions. JMS Co., Ltd. focuses on manufacturing and selling medical equipment and drugs, with a strong emphasis on products such as infusion & transfusion sets, syringe pumps, surgical gowns, and dialysis kits. The company's revenue streams are driven by the sale of these products and the provision of maintenance services. Its geographical segments ensure a diversified market presence, allowing it to serve various healthcare sectors in different countries. JMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JMS Co stock

Intangible Assets of JMS Co is 647.00 M JPY in 2025.

Intangible Assets of JMS Co changed from 680.00 M JPY to 647.00 M JPY, representing a -4.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets JMS Co since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's JMS Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — JMS Co

All Key Metrics — JMS Co